Hepatitis C News and Research

Latest Hepatitis C News and Research

Countrywide variations in chronic HBV burden revealed

A systematic review of the worldwide prevalence of chronic hepatitis B virus infection finds wide variation between countries.

3 Sep 2015

Risk score predicts ACLF risk in chronic HBV patients

A risk score incorporating routinely collected clinical information can identify patients with chronic hepatitis B virus infection at high risk of developing acute-on-chronic liver failure following severe acute exacerbation, research suggests.

3 Sep 2015

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

A research team led by Kezhong Zhang, Ph.D., at the Wayne State University School of Medicine's Center for Molecular Medicine and Genetics, has discovered that exposure to air pollution has a direct adverse health effect on the liver and causes liver fibrosis, an illness associated with metabolic disease and liver cancer.

3 Sep 2015

World leaders meet at World Hepatitis Summit to discuss prevention strategies for viral hepatitis

Today marks the start of the first-ever World Hepatitis Summit hosted in Glasgow, Scotland, at the Scottish Exhibition and Conference Centre.

3 Sep 2015

Ascletis completes US$35 million (RMB 220 million) financing

Ascletis announced today the completion of a US$35 million (RMB 220 million) financing. The investment was led by C-Bridge Capital, joined by Tasly Pharmaceutical and Singapore-based Pavilion Capital. The valuation of the Company before financing was US$300 million.

2 Sep 2015

World Hepatitis Summit highlights need to develop national programmes that can eliminate viral hepatitis

Participants at the first-ever World Hepatitis Summit will urge countries to develop national programmes that can ultimately eliminate viral hepatitis as a problem of public health concern.

2 Sep 2015

ECHO Autism program to be expanded to additional 10 sites

Dr. Kristin Sohl, a pediatrician at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders, will expand the growing ECHO Autism program, which launched in March, to an additional 10 sites.

2 Sep 2015

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar Therapeutics announced today that it has received a $40 million cash payment under a license agreement with AstraZeneca. The payment was triggered by the first commercial sale of MOVENTIG (naloxegol) in Germany.

1 Sep 2015

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.

31 Aug 2015

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).

31 Aug 2015

Vaccine exemption levels low, vaccination rates high in U.S.

Vaccine exemption levels for kindergarteners are low for most states and infant vaccination rates are high nationally, according to data from two reports published in this week's Morbidity and Mortality Weekly Report.

28 Aug 2015

Researchers identify new virus that plays role in rare type of liver cancer

More than a cause of a simple infection, viruses are often involved in the development of serious diseases. Such is the case with liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus.

28 Aug 2015

Yale study identifies new barrier to caring for chronic hepatitis C patients

Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.

27 Aug 2015

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

For the first time, UK physicians have demonstrated that antiviral-based therapies have the potential to protect humans from the deadly Ebola virus. The report, published in The Lancet Infectious Diseases journal, describes a case-series of eight British health-care workers who were evacuated to the Royal Free Hospital in London, UK after possible accidental exposure to Ebola virus in Sierra Leone between January and March 2015.

26 Aug 2015

Researchers discover new hepatitis A-like virus in seals

Scientists in the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis A.

26 Aug 2015

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma Limited, a clinical-stage biotechnology company, is pleased to announce the closing of its U.S. initial public offering of 1,500,000 American Depositary Shares (ADSs), representing 30,000,000 fully paid ordinary shares of Benitec, together with warrants to purchase 500,000 ADSs, representing 10,000,000 fully paid ordinary shares.

24 Aug 2015

New data shows liver cancer has significantly increased in Queensland since the mid-90s

Incidence rates of the most common type of liver cancer have significantly increased in Queensland since the mid-90s, new data shows.

24 Aug 2015

WHO and health cluster partners cope with health needs of internally displaced persons in South Sudan

The World Health Organization and partners are racing to cope with the health needs of thousands of internally displaced persons (IDPs) in northeastern South Sudan where fighting continues and the humanitarian situation remains dire.

21 Aug 2015

Multi-national group of scientists developing new test for Hepatocellular Carcinoma

A group of clinicians and geochemists are working to develop a test for the most common form of primary liver cancer, HCC (Hepatocellular Carcinoma). HCC kills over 600,000 people worldwide every year.

19 Aug 2015

Discovery allows study of naturally occurring forms of HCV in the lab

Worldwide, 185 million people have chronic hepatitis C. Since the late 1980s, when scientists discovered the virus that causes the infection, they have struggled to find ways to grow it in human cells in the lab -- an essential part of learning how the virus works and developing new effective treatments.

19 Aug 2015

Hepatitis C News and Research

Latest Hepatitis C News and Research

Countrywide variations in chronic HBV burden revealed

Risk score predicts ACLF risk in chronic HBV patients

Inhalation exposure to PM2.5 pollution triggers liver fibrosis

World leaders meet at World Hepatitis Summit to discuss prevention strategies for viral hepatitis

Ascletis completes US$35 million (RMB 220 million) financing

World Hepatitis Summit highlights need to develop national programmes that can eliminate viral hepatitis

ECHO Autism program to be expanded to additional 10 sites

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Ascletis receives TFDA approval to begin Phase II trial of interferon-free HCV regimen

Vaccine exemption levels low, vaccination rates high in U.S.

Researchers identify new virus that plays role in rare type of liver cancer

Yale study identifies new barrier to caring for chronic hepatitis C patients

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

Researchers discover new hepatitis A-like virus in seals

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

New data shows liver cancer has significantly increased in Queensland since the mid-90s

WHO and health cluster partners cope with health needs of internally displaced persons in South Sudan

Multi-national group of scientists developing new test for Hepatocellular Carcinoma

Discovery allows study of naturally occurring forms of HCV in the lab

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in